{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":2,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":44,"n_cols":5,"rows_kept":44,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[3,2,3,3],[7,2,7,3],[8,2,8,3],[9,2,9,3],[12,2,12,3],[15,2,15,3],[16,2,16,3],[20,2,20,3],[26,2,26,3],[26,4,26,5],[27,2,27,3],[27,4,27,5],[28,2,28,3],[28,4,28,5],[29,2,29,3],[31,2,31,3],[34,2,34,3],[35,2,35,3],[36,2,36,3],[37,2,37,3],[38,2,38,3],[42,2,42,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910455072803321"]
[null,null,"Titolo",null,"Clinical trials handbook [[electronic resource] /] / edited by Shayne Cox Gad"]
[null,null,"Pubbl/distr/stampa",null,"Hoboken, NJ, : Wiley, c2009"]
[null,null,"ISBN",null,"1-282-36844-3"]
[{"$nulls":4},"9786612368448"]
[{"$nulls":4},"0-470-46636-7"]
[{"$nulls":4},"0-470-46635-9"]
[null,null,"Descrizione fisica",null,"1 online resource (1247 p.)"]
[null,null,"Collana",null,"Pharmaceutical Development Series ; ; v.8"]
[null,null,"Disciplina",null,"615.1"]
[{"$nulls":4},"615.580724"]
[{"$nulls":4},"615/.1"]
[null,null,"Soggetti",null,"Drugs - Testing"]
[{"$nulls":4},"Clinical trials"]
[{"$nulls":4},"Electronic books."]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","Description based upon print version of record."]
[null,null,null,"Nota di bibliografia","Includes bibliographical references and index."]
[null,null,"Nota di contenuto",null,"Clinical Trials Handbook; Contents; Preface; Contributors; 1 Introduction to Clinical Trials; 2 Regulatory Requirements for Investigational New Drug; 3 Preclinical Assessment of Safety in Human Subjects; 4 Predicting Human Adverse Drug Reactions from Nonclinical Safety Studies; 5.1 History of Clinical Trial Development and the Pharmaceutical Industry; 5.2 Adaptive Research; 6 Organization and Planning; 7 Process of Data Management; 8 Clinical Trials Data Management; 9.1 Clinical Trials and the Food and Drug Administration; 9.2 Phase I Clinical Trials; 9.3 Phase II Clinical Trials"]
[{"$nulls":4},"9.4 Designing and Conducting Phase III Studies9.5 Phase IV: Postmarketing Trials; 9.6 Phase IV and Postmarketing Clinical Trials; 9.7 Regulatory Approval; 9.8 New Paradigm for Analyzing Adverse Drug Events; 10.1 Clinical Trials in Interventional Cardiology: Focus on XIENCE Drug-Eluting Stent; 10.2 Clinical Trials Involving Oral Diseases; 10.3 Dermatology Clinical Trials; 10.4 Emergency Clinical Trials; 10.5 Gastroenterology; 10.6 Gynecology Randomized Control Trials; 10.7 Special Population Studies (Healthy Patient Studies); 10.8 Musculoskeletal Disorders; 10.9 Oncology"]
[{"$nulls":4},"10.10 Pharmacological Treatment Options for Nonexudative and "]
[{"$nulls":4},"Exudative Age-Related Macular Degeneration10.11 Paediatrics; 10.12 Clinical Trials in Dementia; 10.13 Clinical Trials in Urology; 10.14 Clinical Trials on Cognitive Drugs; 10.15 Bridging Studies in Pharmaceutical Safety Assessment; 10.16 Brief History of Clinical Trials on Viral Vaccines; 11 Methods of Randomization; 12 Randomized Controlled Trials; 13 Cross-Over Designs; 14.1 Biomarkers; 14.2 Biomarkers in Clinical Drug Development: Parallel Analysis of Alzheimer Disease and Multiple Sclerosis; 15 Review Boards"]
[{"$nulls":4},"16 Size of Clinical Trials17 Blinding and Placebo; 18 Pharmacology; 19 Modeling and Simulation in Clinical Drug Development; 20 Monitoring; 21 Inference Following Sequential Clinical Trials; 22 Statistical Methods for Analysis of Clinical Trials; 23 Explanatory and Pragmatic Clinical Trials; 24.1 Ethics of Clinical Research in Durg Trials; 24.2 Ethical Issues in Clinical Research; 25 Regulations; 26 Future Challenges in Design and Ethics of Clinical Trials; 27 Proof-of-Principle/Proof-of-Concept Trials in Drug Development; Index"]
[null,null,null,"Sommario/riassunto","Best practices for conducting effective and safe clinical trials Clinical trials are arguably the most important steps in proving drug effectiveness and safety for public use. They require intensive planning and organization and involve a wide range of disciplines: data management, biostatistics, pharmacology, toxicology, modeling and simulation, regulatory monitoring, ethics, and particular issues for given disease areas. Clinical Trials Handbook provides a comprehensive and thorough reference on the basics and practices of clinical trials. With contributions from a range of"]
[null,"2.","Record Nr.",null,"UNINA9910783395703321"]
[null,null,"Autore",null,"Corazza Eros"]
[null,null,"Titolo",null,"Reflecting the mind [[electronic resource] ] : indexicality and quasi-indexicality / / Eros Corazza"]
[null,null,"Pubbl/distr/stampa",null,"Oxford, : Clarendon"]
[{"$nulls":4},"New York, : Oxford University Press, 2004"]
[null,null,"ISBN",null,"1-281-90666-2"]
[{"$nulls":4},"9786611906665"]
[{"$nulls":4},"0-19-153363-7"]
[null,null,"Descrizione fisica",null,"1 online resource (383 p.)"]
[null,null,"Disciplina",null,"420/.143"]
[null,null,"Soggetti",null,"Indexicals (Semantics)"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","Description based upon print version of record."]
[null,null,null,"Nota di bibliografia","Includes bibliographical references (p. [351]-362) and indexes."]
[null,null,"Nota di contenuto",null,"Contents; Introduction; Chapter 1: Language and Context; Chapter 2: Thought and Context; Chapter 3: A Multiple-Proposition Approach; Chapter 4: Demonstratives, Pure Indexicals, and Essential Indexicals; Chapter 5: The First-Person Pronoun; Chapter 6: Perspectival Thoughts and Psychological Explanation; Chapter 7: Empathy, Imagination, and Reports; Chapter 8: Anaphora, Logophoricity, and Quasi-Indexicality; Chapter 9: Quasi-Indexicality and Puzzling Reports; Conclusion; Bibliography; Index of Names; Index of Subjects"]
[null,null,null,"Sommario/riassunto","Eros Corazza presents a fascinating investigation of the role that indexicals (e.g. 'I', 'she', 'this', 'today', 'here') play in our thought. Indexicality is crucial to the understanding of such puzzling issues as the nature of the self, the nature of perception, social interaction, psychological pathologies, and psychological development. Corazza draws on work from philosophy, linguistics, and psychology to illuminate this key aspect of the relation between mind and world. By highlighting how indexical thoughts are irreducible and intrinsically perspectival, Corazza shows how we can depict so"]